These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 143149

  • 1. [Frequency effects of ipratropium bromide].
    Gräwe G, Bender F, Brisse B, Kappenstein C, Pietsch M.
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1233-6. PubMed ID: 143149
    [No Abstract] [Full Text] [Related]

  • 2. [Action of an atropine derivative, Ipratropiumbromide (SCH 1000) in bradycardia].
    Flohr E, Bischoff KO, Hager W.
    Med Welt; 1979 Feb 23; 30(8):292-7. PubMed ID: 154603
    [No Abstract] [Full Text] [Related]

  • 3. Arrhythmias and antiarrhythmic drugs.
    Urthaler F.
    Ala J Med Sci; 1984 Jul 23; 21(3):275-83. PubMed ID: 6476289
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F.
    Kardiol Pol; 1992 Jul 23; 36(2):92-6. PubMed ID: 1583832
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Banasiak W, Metner E.
    Wiad Lek; 1987 Jan 15; 40(2):100-5. PubMed ID: 3296463
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [New method for direct study of antiarrhythmic drugs in man. Electrophysiological effects and criteria for interpretation].
    Domenichelli B, Manzoli U, Schiavoni G, Feraco E.
    Minerva Cardioangiol; 1974 Feb 15; 22(2):71-89. PubMed ID: 4820118
    [No Abstract] [Full Text] [Related]

  • 11. [Choice of cardiac antiarrhythmia agents].
    Kappenberger L, Biollaz J.
    Ther Umsch; 1987 Aug 15; 44(8):591-5. PubMed ID: 3672412
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF, Georgiopoulos G, Halkidis H, Attuel P, Maisonblanche P, Coumel P.
    Arch Mal Coeur Vaiss; 1981 Dec 15; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract] [Full Text] [Related]

  • 14. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
    Motté G.
    Arch Mal Coeur Vaiss; 1981 Dec 15; 74 Spec No():7-16. PubMed ID: 6280631
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of ventricular arrhythmias.
    Fogoros RN.
    Am Fam Physician; 1986 Mar 15; 33(3):236-46. PubMed ID: 3953344
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical indications of different drugs for refractory arrhythmias (author's transl)].
    Leclercq JF, Coumel P.
    Ther Umsch; 1982 Feb 15; 39(2):128-36. PubMed ID: 7071785
    [No Abstract] [Full Text] [Related]

  • 19. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J, Scampardonis G, Alexandrides K, González Hermosillo JA.
    Arch Inst Cardiol Mex; 1972 Feb 15; 42(4):629-34. PubMed ID: 5073709
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.